Discontinued — last reported Q3 '22
Business Segments · Revenue
LabCorp Diagnostics — Revenue
Labcorp Holdings LabCorp Diagnostics — Revenue decreased by 2.1% to $2.21B in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 15.7%, from $2.62B to $2.21B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2022
Rolls up toTotal Revenue
How to read this metric
An increase signals higher market demand, successful service expansion, or effective pricing strategies.
Detailed definition
This metric represents the total gross income generated from diagnostic testing services, including routine clinical scr...
Peer comparison
Comparable to revenue metrics for other large-scale clinical laboratory providers and diagnostic service firms.
Metric ID:
lh_segment_labcorp_diagnostics_revenuesHistorical Data
5 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|
| Value | $2.37B | $2.62B | $2.45B | $2.26B | $2.21B |
| QoQ Change | — | +10.7% | -6.2% | -8.1% | -2.1% |
| YoY Change | — | — | — | -4.7% | -15.7% |
Range$2.21B – $2.62B
CAGR-6.7%
Avg YoY Growth-10.2%
Median YoY Growth-10.2%
Current Streak3 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's labcorp diagnostics — revenue?
- Labcorp Holdings (LH) reported labcorp diagnostics — revenue of $2.21B in Q3 2022.
- How has Labcorp Holdings's labcorp diagnostics — revenue changed year-over-year?
- Labcorp Holdings's labcorp diagnostics — revenue decreased by 15.7% year-over-year, from $2.62B to $2.21B.
- What does labcorp diagnostics — revenue mean?
- Total sales generated by the diagnostics business segment before any expenses.